Supporting clients with everything from preclinical to Phase III trials, the role of a Bioanalytical department is certainly one of variation and importance.

With services ranging from development, validation, and application of bioanalytical methods and protocols, through to the preparation of sampling manuals for clinical workplaces and onwards to the analyses of active ingredients and/or metabolites in biological samples, the lab needs coordination, experience, and leadership in equal measure.

Boasting nine modern LC/MS/MS devices with triple quadrupoles, six of which are equipped with a 2-channel HPLC system, it’s fair to say that QUINTA-ANALYTICA’s Bioanalytical department is one such world-class facility.

Headed by highly experienced Vladimír Kubeš, Quinta’s BioA department hosts a database that currently contains around 300 bioanalytical methods developed and validated in-house in accordance with GLP rules, ICH/FDA, and EMEA guidelines.

Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.

Speak to Vladimir and his team to learn more.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.